Viking Therapeutics Raises $547.8 Million via Equity Sale and 2.00% Convertible Notes

Viking Therapeutics completed twin capital raises, securing approximately $547.8 million in combined net proceeds. The company sold 7,857,143 common shares at $35.00 per share, with the underwriters fully exercising their option for 1,178,571 additional shares, for about $297.0 million in net proce…